Northern Trust Corp Applied Therapeutics Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 761,060 shares of APLT stock, worth $449,025. This represents 0.0% of its overall portfolio holdings.

Number of Shares

761,060

Previous 233,784 225.54%

Holding current value

$449,025

Previous $1.09 Million 492.94%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.35 - $8.5 $2.29 Million - $4.48 Million	527,276 Added 225.54%	761,060 $6.47 Million
Q2 2024 Aug 14, 2024	BUY	$4.04 - $6.37 $514,417 - $811,098	127,331 Added 119.61%	233,784 $1.09 Million
Q1 2024 May 14, 2024	SELL	$2.25 - $7.4 $324 - $1,065	-144 Reduced 0.14%	106,453 $723,000
Q4 2023 Feb 13, 2024	BUY	$1.84 - $3.35 $14,076 - $25,627	7,650 Added 7.73%	106,597 $357,000
Q3 2023 Nov 13, 2023	SELL	$1.26 - $2.77 $12,945 - $28,458	-10,274 Reduced 9.41%	98,947 $246,000
Q2 2023 Aug 11, 2023	BUY	$0.77 - $1.8 $44,860 - $104,869	58,261 Added 114.33%	109,221 $139,000
Q3 2022 Nov 14, 2022	BUY	$0.86 - $1.55 $13,217 - $23,821	15,369 Added 43.18%	50,960 $47,000
Q2 2022 Aug 12, 2022	SELL	$0.76 - $2.64 $97,881 - $340,010	-128,792 Reduced 78.35%	35,591 $34,000
Q1 2022 May 13, 2022	SELL	$1.48 - $6.22 $19,681 - $82,713	-13,298 Reduced 7.48%	164,383 $347,000
Q4 2021 Feb 08, 2022	SELL	$8.77 - $18.29 $4,551 - $9,492	-519 Reduced 0.29%	177,681 $1.59 Million
Q3 2021 Nov 15, 2021	SELL	$13.54 - $22.06 $159,826 - $260,396	-11,804 Reduced 6.21%	178,200 $2.96 Million
Q2 2021 Aug 13, 2021	BUY	$14.05 - $25.04 $155,041 - $276,316	11,035 Added 6.17%	190,004 $3.95 Million
Q1 2021 May 12, 2021	BUY	$16.57 - $28.65 $172,675 - $298,561	10,421 Added 6.18%	178,969 $3.36 Million
Q4 2020 Feb 11, 2021	SELL	$15.44 - $24.23 $59,629 - $93,576	-3,862 Reduced 2.24%	168,548 $3.71 Million
Q3 2020 Nov 16, 2020	BUY	$19.43 - $35.36 $1.22 Million - $2.22 Million	62,853 Added 57.37%	172,410 $3.58 Million
Q2 2020 Aug 14, 2020	BUY	$29.41 - $51.23 $209,134 - $364,296	7,111 Added 6.94%	109,557 $3.96 Million
Q1 2020 May 14, 2020	BUY	$19.54 - $55.47 $836,116 - $2.37 Million	42,790 Added 71.73%	102,446 $3.35 Million
Q4 2019 Feb 14, 2020	BUY	$10.16 - $28.14 $370,210 - $1.03 Million	36,438 Added 156.94%	59,656 $1.63 Million
Q3 2019 Nov 13, 2019	BUY	$8.08 - $10.99 $129,894 - $176,675	16,076 Added 225.09%	23,218 $256,000
Q2 2019 Aug 13, 2019	BUY	$8.1 - $10.05 $57,850 - $71,777	7,142 New	7,142 $59,000

Others Institutions Holding APLT

# of Institutions

139

Shares Held

111M

Call Options Held

1.68M

Put Options Held

1.91M

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $28.3M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Applied Therapeutics Inc. Transaction History